Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The companies can now ...
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance ...
The US Food and Drug Administration intends to put a “black box” warning on Covid-19 vaccines, according to two people familiar with the agency’s plans.
The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...
The FDA is reportedly preparing to add what's known as a "black box" warning to Covid shots by the end of the year, marking a ...
Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become stricter.
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
The FDA is planning its strongest safety alert for Covid-19 vaccines as debates over risks, including myocarditis in young ...
The Food and Drug Administration is scrutinizing the common practice of giving coronavirus and flu shots together, signaling a reversal of years of federal guidance and a broader crackdown on ...
The Food and Drug Administration (FDA) is investigating whether the COVID-19 vaccines were associated with any deaths across ...